Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
Launched by UNIVERSITY CHILDREN'S HOSPITAL, ZURICH · Apr 7, 2016
Trial Information
Current as of June 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the genetic causes of primary immunodeficiency (PID), a condition where the immune system doesn't function properly. People with PID often experience frequent and severe infections or other health issues related to the immune system. The study aims to understand these genetic factors by comparing individuals suspected of having PID with healthy individuals. This research could help identify new genetic causes of immunodeficiencies and improve future treatments.
If you or someone you know has symptoms suggesting primary immunodeficiency, you may be eligible to participate in this study, which is open to patients, healthy relatives, and volunteers of all ages and genders. Participants will need to provide consent for their information to be used in the study. There are no specific exclusions, making it easier for many individuals to join. By participating, you could help advance our understanding of these immune system disorders, which may lead to better management and care for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with suspected PID, healthy relative or healthy volunteer
- • consent
- Exclusion Criteria:
- • none
About University Children's Hospital, Zurich
The University Children's Hospital Zurich is a leading academic medical institution dedicated to advancing pediatric healthcare through innovative research and clinical excellence. Affiliated with the University of Zurich, the hospital specializes in a wide range of pediatric disciplines, offering comprehensive care to children and adolescents. As a prominent sponsor of clinical trials, the institution is committed to exploring new therapies and improving treatment protocols, ensuring that young patients benefit from the latest advancements in medicine. With a focus on collaboration, the hospital engages in partnerships with researchers, healthcare professionals, and pharmaceutical companies to drive impactful studies that enhance the health and well-being of children globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, Zh, Switzerland
Basel, , Switzerland
Patients applied
Trial Officials
Jana M Pachlopnik Schmid, MD PhD
Principal Investigator
University Children's Hospital, Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials